Docusign (NASDAQ:DOCU – Free Report) had its price objective decreased by Citizens Jmp from $124.00 to $86.00 in a research report report published on Wednesday,Benzinga reports. Citizens Jmp currently has a market outperform rating on the stock.
A number of other research analysts have also recently commented on the company. Evercore reduced their target price on Docusign from $92.00 to $80.00 and set an “in-line” rating on the stock in a research note on Friday, December 5th. Bank of America dropped their price target on Docusign from $102.00 to $82.00 and set a “neutral” rating for the company in a research note on Friday, December 5th. Royal Bank Of Canada cut their price objective on Docusign from $95.00 to $70.00 and set a “sector perform” rating for the company in a report on Monday, January 5th. Robert W. Baird reduced their price objective on Docusign from $75.00 to $55.00 and set a “neutral” rating on the stock in a research report on Wednesday. Finally, Wedbush decreased their price objective on Docusign from $85.00 to $75.00 and set a “neutral” rating on the stock in a report on Friday, December 5th. Five analysts have rated the stock with a Buy rating and sixteen have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $66.67.
Docusign Price Performance
Docusign (NASDAQ:DOCU – Get Free Report) last posted its quarterly earnings data on Tuesday, March 17th. The company reported $1.01 earnings per share for the quarter, beating the consensus estimate of $0.95 by $0.06. Docusign had a net margin of 9.60% and a return on equity of 16.86%. The firm had revenue of $836.86 million for the quarter, compared to analysts’ expectations of $828.23 million. During the same quarter last year, the company posted $0.86 EPS. The business’s quarterly revenue was up 7.8% on a year-over-year basis. On average, research analysts expect that Docusign will post 1.17 EPS for the current fiscal year.
Docusign announced that its Board of Directors has initiated a share repurchase plan on Tuesday, March 17th that allows the company to buyback $2.00 billion in shares. This buyback authorization allows the company to reacquire up to 21% of its shares through open market purchases. Shares buyback plans are generally an indication that the company’s board of directors believes its stock is undervalued.
Insider Buying and Selling at Docusign
In other Docusign news, CFO Blake Jeffrey Grayson sold 6,500 shares of the company’s stock in a transaction dated Friday, January 9th. The stock was sold at an average price of $70.00, for a total value of $455,000.00. Following the completion of the sale, the chief financial officer owned 111,713 shares in the company, valued at $7,819,910. This represents a 5.50% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider Robert Chatwani sold 16,696 shares of the firm’s stock in a transaction dated Wednesday, March 18th. The stock was sold at an average price of $48.10, for a total value of $803,077.60. Following the completion of the transaction, the insider directly owned 72,458 shares in the company, valued at $3,485,229.80. This trade represents a 18.73% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 68,173 shares of company stock valued at $4,324,684 in the last ninety days. 1.01% of the stock is currently owned by company insiders.
Hedge Funds Weigh In On Docusign
Large investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its position in shares of Docusign by 1.1% in the third quarter. Vanguard Group Inc. now owns 21,625,551 shares of the company’s stock worth $1,558,986,000 after purchasing an additional 225,525 shares during the period. State Street Corp increased its stake in shares of Docusign by 0.9% in the fourth quarter. State Street Corp now owns 8,193,805 shares of the company’s stock worth $560,456,000 after purchasing an additional 77,008 shares in the last quarter. Capital World Investors raised its position in shares of Docusign by 38.1% during the 4th quarter. Capital World Investors now owns 5,815,804 shares of the company’s stock valued at $397,801,000 after purchasing an additional 1,603,900 shares during the period. American Century Companies Inc. lifted its stake in shares of Docusign by 1.6% during the 2nd quarter. American Century Companies Inc. now owns 5,564,318 shares of the company’s stock valued at $433,405,000 after buying an additional 86,560 shares in the last quarter. Finally, Geode Capital Management LLC lifted its stake in shares of Docusign by 0.5% during the 4th quarter. Geode Capital Management LLC now owns 4,084,463 shares of the company’s stock valued at $278,665,000 after buying an additional 18,873 shares in the last quarter. Hedge funds and other institutional investors own 77.64% of the company’s stock.
Key Headlines Impacting Docusign
Here are the key news stories impacting Docusign this week:
- Positive Sentiment: Q4 beat — DocuSign reported Q4 revenue and EPS modestly above consensus and reiterated growth guidance, showing continued subscription momentum and giving a near‑term fundamental support for the stock. Proactive: DocuSign beats Q4 estimates
- Positive Sentiment: Large buyback authorized — The board approved a $2.0 billion increase (bringing total authorization to roughly $2.6B), representing a material portion of market cap; buybacks are a direct capital‑allocation tool that can support the share price and signal management confidence. DocuSign press release: buyback
- Neutral Sentiment: Higher trading volume — Volume spiked after the earnings release, which raises short‑term volatility and can amplify both rebounds and selloffs depending on flow. American Banking News: Volume Increase After Earnings
- Neutral Sentiment: Short‑interest reporting appears inconsistent — March short‑interest entries in the feed show anomalous “0”/NaN values, so there’s no clear short‑flow signal from these data points at this time.
- Negative Sentiment: Analyst cuts and cautious notes — Multiple major brokerages trimmed price targets and moved to more cautious ratings (examples include Morgan Stanley, RBC, UBS, JPMorgan, Piper Sandler, Wells Fargo and others), reducing near‑term upside expectations and contributing to selling pressure. American Banking News: Morgan Stanley Lowers Price Target
- Negative Sentiment: Insider sale disclosed — Senior executive Robert Chatwani sold ~16.7k shares (~$803k); while single insider sales can be routine, the filing has weighed on sentiment alongside the analyst downgrades. SEC Form 4: Insider Sale
About Docusign
DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.
DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.
See Also
Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.
